These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 26910513)
1. Integrating Anatomic and Functional Dual-Mode Magnetic Resonance Imaging: Design and Applicability of a Bifunctional Contrast Agent. Ni D; Shen Z; Zhang J; Zhang C; Wu R; Liu J; Yi M; Wang J; Yao Z; Bu W; Shi J ACS Nano; 2016 Mar; 10(3):3783-90. PubMed ID: 26910513 [TBL] [Abstract][Full Text] [Related]
2. Dual T Suárez-García S; Arias-Ramos N; Frias C; Candiota AP; Arús C; Lorenzo J; Ruiz-Molina D; Novio F ACS Appl Mater Interfaces; 2018 Nov; 10(45):38819-38832. PubMed ID: 30351897 [TBL] [Abstract][Full Text] [Related]
3. Renal Clearable Peptide Functionalized NaGdF Chen H; Li X; Liu F; Zhang H; Wang Z Mol Pharm; 2017 Sep; 14(9):3134-3141. PubMed ID: 28727430 [TBL] [Abstract][Full Text] [Related]
4. Non-caloric sweetener provides magnetic resonance imaging contrast for cancer detection. Bagga P; Haris M; D'Aquilla K; Wilson NE; Marincola FM; Schnall MD; Hariharan H; Reddy R J Transl Med; 2017 May; 15(1):119. PubMed ID: 28558795 [TBL] [Abstract][Full Text] [Related]
5. Dual-targeting and excretable ultrasmall SPIONs for T Du C; Liu X; Hu H; Li H; Yu L; Geng D; Chen Y; Zhang J J Mater Chem B; 2020 Mar; 8(11):2296-2306. PubMed ID: 32100784 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Tumor Visualization through MRI Off-On Switching of NaGdF Yi Z; Luo Z; Barth ND; Meng X; Liu H; Bu W; All A; Vendrell M; Liu X Adv Mater; 2019 Sep; 31(37):e1901851. PubMed ID: 31364218 [TBL] [Abstract][Full Text] [Related]
7. Tuning the relaxation rates of dual-mode T(1)/T(2) nanoparticle contrast agents: a study into the ideal system. Keasberry NA; Bañobre-López M; Wood C; Stasiuk GJ; Gallo J; Long NJ Nanoscale; 2015 Oct; 7(38):16119-28. PubMed ID: 26371437 [TBL] [Abstract][Full Text] [Related]
8. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Caravan P Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207 [TBL] [Abstract][Full Text] [Related]
9. Ultrasmall Ferrite Nanoparticles Synthesized via Dynamic Simultaneous Thermal Decomposition for High-Performance and Multifunctional T Zhang H; Li L; Liu XL; Jiao J; Ng CT; Yi JB; Luo YE; Bay BH; Zhao LY; Peng ML; Gu N; Fan HM ACS Nano; 2017 Apr; 11(4):3614-3631. PubMed ID: 28371584 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding. Liu Y; Wu X; Sun X; Wang D; Zhong Y; Jiang D; Wang T; Yu D; Zhang N Int J Nanomedicine; 2017; 12():5039-5052. PubMed ID: 28765707 [TBL] [Abstract][Full Text] [Related]
12. Europium-doped gadolinium sulfide nanoparticles as a dual-mode imaging agent for T1-weighted MR and photoluminescence imaging. Jung J; Kim MA; Cho JH; Lee SJ; Yang I; Cho J; Kim SK; Lee C; Park JK Biomaterials; 2012 Aug; 33(24):5865-74. PubMed ID: 22617320 [TBL] [Abstract][Full Text] [Related]
13. A pH-Responsive Yolk-Like Nanoplatform for Tumor Targeted Dual-Mode Magnetic Resonance Imaging and Chemotherapy. Sun X; Du R; Zhang L; Zhang G; Zheng X; Qian J; Tian X; Zhou J; He J; Wang Y; Wu Y; Zhong K; Cai D; Zou D; Wu Z ACS Nano; 2017 Jul; 11(7):7049-7059. PubMed ID: 28665575 [TBL] [Abstract][Full Text] [Related]
14. Dual assessment of kidney perfusion and pH by exploiting a dynamic CEST-MRI approach in an acute kidney ischemia-reperfusion injury murine model. Irrera P; Consolino L; Cutrin JC; Zöllner FG; Longo DL NMR Biomed; 2020 Jun; 33(6):e4287. PubMed ID: 32153058 [TBL] [Abstract][Full Text] [Related]
15. Development of PEGylated KMnF3 nanoparticles as a T1-weighted contrast agent: chemical synthesis, in vivo brain MR imaging, and accounting for high relaxivity. Liu ZJ; Song XX; Tang Q Nanoscale; 2013 Jun; 5(11):5073-9. PubMed ID: 23640287 [TBL] [Abstract][Full Text] [Related]
16. A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging. Sun J; Li X; Chen A; Cai W; Peng X; Li L; Fan B; Wang L; Zhang H; Zhang R Int J Nanomedicine; 2019; 14():9893-9904. PubMed ID: 31908447 [TBL] [Abstract][Full Text] [Related]
17. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063 [TBL] [Abstract][Full Text] [Related]
18. Characterization of Fe3O4/SiO2/Gd2O(CO3)2 core/shell/shell nanoparticles as T1 and T2 dual mode MRI contrast agent. Yang M; Gao L; Liu K; Luo C; Wang Y; Yu L; Peng H; Zhang W Talanta; 2015 Jan; 131():661-5. PubMed ID: 25281156 [TBL] [Abstract][Full Text] [Related]
19. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine. McVicar N; Li AX; Meakin SO; Bartha R NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190 [TBL] [Abstract][Full Text] [Related]
20. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis. Chen J; Zhang WJ; Guo Z; Wang HB; Wang DD; Zhou JJ; Chen QW ACS Appl Mater Interfaces; 2015 Mar; 7(9):5373-83. PubMed ID: 25685956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]